LENZING AG (LEN.DE) Stock Fundamental Analysis
FRA:LEN - Deutsche Boerse Ag - AT0000644505 - Common Stock - Currency: EUR
Overall LEN gets a fundamental rating of 3 out of 10. We evaluated LEN against 65 industry peers in the Chemicals industry. LEN may be in some trouble as it scores bad on both profitability and health. LEN has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year LEN has reported negative net income.
LEN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LEN reported negative net income in multiple years.
LEN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of -2.47%, LEN is not doing good in the industry: 66.15% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -9.17%, LEN is doing worse than 69.23% of the companies in the same industry.
With a Return On Invested Capital value of 2.95%, LEN perfoms like the industry average, outperforming 55.38% of the companies in the same industry.
LEN had an Average Return On Invested Capital over the past 3 years of 1.29%. This is significantly below the industry average of 6.60%.
The last Return On Invested Capital (2.95%) for LEN is above the 3 year average (1.29%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.47% | ||
| ROE | -9.17% | ||
| ROIC | 2.95% |
ROA(3y)-5.64%
ROA(5y)-2.94%
ROE(3y)-20.41%
ROE(5y)-11%
ROIC(3y)1.29%
ROIC(5y)1.63%
1.3 Margins
LEN has a Operating Margin of 5.99%. This is comparable to the rest of the industry: LEN outperforms 56.92% of its industry peers.
In the last couple of years the Operating Margin of LEN has declined.
LEN has a worse Gross Margin (20.28%) than 70.77% of its industry peers.
In the last couple of years the Gross Margin of LEN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.99% | ||
| PM (TTM) | N/A | ||
| GM | 20.28% |
OM growth 3Y-21.19%
OM growth 5Y-11.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.92%
GM growth 5Y-14.28%
2. Health
2.1 Basic Checks
LEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
LEN has about the same amout of shares outstanding than it did 1 year ago.
LEN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LEN has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.20, we must say that LEN is in the distress zone and has some risk of bankruptcy.
LEN has a worse Altman-Z score (1.20) than 78.46% of its industry peers.
The Debt to FCF ratio of LEN is 22.25, which is on the high side as it means it would take LEN, 22.25 years of fcf income to pay off all of its debts.
LEN's Debt to FCF ratio of 22.25 is in line compared to the rest of the industry. LEN outperforms 49.23% of its industry peers.
LEN has a Debt/Equity ratio of 1.37. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.37, LEN is not doing good in the industry: 83.08% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.37 | ||
| Debt/FCF | 22.25 | ||
| Altman-Z | 1.2 |
ROIC/WACC0.48
WACC6.17%
2.3 Liquidity
A Current Ratio of 1.57 indicates that LEN should not have too much problems paying its short term obligations.
LEN has a Current ratio (1.57) which is in line with its industry peers.
LEN has a Quick Ratio of 1.57. This is a bad value and indicates that LEN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.92, LEN is doing worse than 67.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.57 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 79.94% over the past year.
The Revenue has been growing slightly by 5.45% in the past year.
Measured over the past years, LEN shows a small growth in Revenue. The Revenue has been growing by 4.82% on average per year.
EPS 1Y (TTM)79.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.46%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y6.67%
Revenue growth 5Y4.82%
Sales Q2Q%4.83%
3.2 Future
LEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.54% yearly.
LEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.54% yearly.
EPS Next Y104.55%
EPS Next 2Y107.39%
EPS Next 3Y60.99%
EPS Next 5Y44.54%
Revenue Next Year8.4%
Revenue Next 2Y6.14%
Revenue Next 3Y4.71%
Revenue Next 5Y2.54%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for LEN. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 11.85, the valuation of LEN can be described as very reasonable.
Based on the Price/Forward Earnings ratio, LEN is valued a bit cheaper than the industry average as 75.38% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.17, LEN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.85 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LEN indicates a rather cheap valuation: LEN is cheaper than 87.69% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LEN is valued cheaper than 84.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.85 | ||
| EV/EBITDA | 5.5 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LEN's earnings are expected to grow with 60.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y107.39%
EPS Next 3Y60.99%
5. Dividend
5.1 Amount
No dividends for LEN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:LEN (6/4/2025, 7:00:00 PM)
26.2
+0.2 (+0.77%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners19.14%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.01B
Analysts51.67
Price Target33.16 (26.56%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.74
Dividend Growth(5Y)-31.68%
DP-23.81%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.71%
PT rev (3m)-1.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)111.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)4.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.85 | ||
| P/S | 0.38 | ||
| P/FCF | 10.85 | ||
| P/OCF | 4.07 | ||
| P/B | 0.77 | ||
| P/tB | 0.77 | ||
| EV/EBITDA | 5.5 |
EPS(TTM)-3.11
EYN/A
EPS(NY)2.21
Fwd EY8.44%
FCF(TTM)2.42
FCFY9.22%
OCF(TTM)6.44
OCFY24.6%
SpS69.8
BVpS33.86
TBVpS33.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.47% | ||
| ROE | -9.17% | ||
| ROCE | 4.19% | ||
| ROIC | 2.95% | ||
| ROICexc | 3.32% | ||
| ROICexgc | 3.32% | ||
| OM | 5.99% | ||
| PM (TTM) | N/A | ||
| GM | 20.28% | ||
| FCFM | 3.46% |
ROA(3y)-5.64%
ROA(5y)-2.94%
ROE(3y)-20.41%
ROE(5y)-11%
ROIC(3y)1.29%
ROIC(5y)1.63%
ROICexc(3y)1.51%
ROICexc(5y)2.07%
ROICexgc(3y)1.52%
ROICexgc(5y)2.09%
ROCE(3y)1.84%
ROCE(5y)2.31%
ROICexcg growth 3Y-16.94%
ROICexcg growth 5Y-17.21%
ROICexc growth 3Y-16.83%
ROICexc growth 5Y-17.09%
OM growth 3Y-21.19%
OM growth 5Y-11.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.92%
GM growth 5Y-14.28%
F-Score6
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.37 | ||
| Debt/FCF | 22.25 | ||
| Debt/EBITDA | 3.72 | ||
| Cap/Depr | 48.54% | ||
| Cap/Sales | 5.77% | ||
| Interest Coverage | 1.25 | ||
| Cash Conversion | 51.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.57 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.2 |
F-Score6
WACC6.17%
ROIC/WACC0.48
Cap/Depr(3y)130.66%
Cap/Depr(5y)264.56%
Cap/Sales(3y)14.58%
Cap/Sales(5y)24.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.46%
EPS Next Y104.55%
EPS Next 2Y107.39%
EPS Next 3Y60.99%
EPS Next 5Y44.54%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y6.67%
Revenue growth 5Y4.82%
Sales Q2Q%4.83%
Revenue Next Year8.4%
Revenue Next 2Y6.14%
Revenue Next 3Y4.71%
Revenue Next 5Y2.54%
EBIT growth 1Y137.23%
EBIT growth 3Y-15.93%
EBIT growth 5Y-7.56%
EBIT Next Year505.76%
EBIT Next 3Y92.08%
EBIT Next 5Y67.42%
FCF growth 1Y112.09%
FCF growth 3YN/A
FCF growth 5Y207.34%
OCF growth 1Y245.86%
OCF growth 3Y-6.46%
OCF growth 5Y5.68%